StockTipsArenaBeta

BUY Sai Life Sciences — Ashish Kyal, Waves Strategy Advisors

BUYSai Life Sciences

byAshish Kyal, Waves Strategy AdvisorsHorizon: NA (inferred Swing (≤2wk))20 Aug 2026via ET Now (Live)

Entry₹1,478.2Inferred
Target₹1,600
Total upside +8.24% (call closed)
Stop loss₹1,420-3.94% risk
At expiry₹1,592.72 Sept 2026, 3:30 pm
Expired+7.75%
Follow Ashish Kyal for new calls(22% target hit, 112 closed calls)Get alertsWatch SAILIFE for new buy/sell callsGet alertsSee 1 active Swing call on SAILIFESee 264 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 2 Sept 2026
5 supporting2 neutral1 opposing
Supports the BUY call (5)

1 other SEBI-registered advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · same horizon·2 Sept · today

SAI LIFE SCIENCES Share Price: Fresh 52-Week High Analysis

NewsGoogle News·27 Aug · 6d ago

(opens in new tab)

Jefferies rates 5 CRDMO stocks ‘Buy’ with up to 20% upside potential

NewsGoogle News·27 Aug · 6d ago

(opens in new tab)

SAI LIFE SCIENCES LIMITED Share Price Hits One-Year High

NewsGoogle News·20 Aug · 2w ago

(opens in new tab)

SAI LIFE SCIENCES LIMITED Share Price Today: 3.06% Gain

NewsGoogle News·20 Aug · 2w ago

(opens in new tab)
Neutral / worth noting (2)

Sai Life Sciences files FY26 BRSR and ESG Databook on August 25

NewsGoogle News·25 Aug · 1w ago

(opens in new tab)

Sai Life Sciences schedules 27th AGM for September 17, 2026

NewsGoogle News·24 Aug · 1w ago

(opens in new tab)
Weighs against the BUY call (1)

Sai Life Sciences Share Price Tanks Over 6% Even As Q1 Profit Rises 21%; Revenue Rises To Rs 554 Crore

NewsNdtv-Profit·7 Aug · 4w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.